Fate Therapeutics, Inc. (FATE)
After hours:
- GlobeNewswire
Fate Therapeutics to Present at 2024 Cantor Global Healthcare Conference
SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that the Company will present at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 12:45 PM ET in New York, New York. A live webcast, if recorded, of the p
- Zacks
Why Is Fate Therapeutics (FATE) Up 18.7% Since Last Earnings Report?
Fate Therapeutics (FATE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Simply Wall St.
Broker Revenue Forecasts For Fate Therapeutics, Inc. (NASDAQ:FATE) Are Surging Higher
Celebrations may be in order for Fate Therapeutics, Inc. ( NASDAQ:FATE ) shareholders, with the analysts delivering a...
